These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16932353)

  • 21. A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity.
    Blom AM; Bergström F; Edey M; Diaz-Torres M; Kavanagh D; Lampe A; Goodship JA; Strain L; Moghal N; McHugh M; Inward C; Tomson C; Frémeaux-Bacchi V; Villoutreix BO; Goodship TH
    J Immunol; 2008 May; 180(9):6385-91. PubMed ID: 18424762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement regulatory genes and hemolytic uremic syndromes.
    Kavanagh D; Richards A; Atkinson J
    Annu Rev Med; 2008; 59():293-309. PubMed ID: 17705684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
    Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.
    Jalanko H; Peltonen S; Koskinen A; Puntila J; Isoniemi H; Holmberg C; Pinomäki A; Armstrong E; Koivusalo A; Tukiainen E; Mäkisalo H; Saland J; Remuzzi G; de Cordoba S; Lassila R; Meri S; Jokiranta TS
    Am J Transplant; 2008 Jan; 8(1):216-21. PubMed ID: 17973958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined kidney and liver transplantation for familial haemolytic uraemic syndrome.
    Remuzzi G; Ruggenenti P; Codazzi D; Noris M; Caprioli J; Locatelli G; Gridelli B
    Lancet; 2002 May; 359(9318):1671-2. PubMed ID: 12020532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical HUS and complement dysregulation.
    Goodship TH
    J Am Soc Nephrol; 2006 Jul; 17(7):1775-6. PubMed ID: 16790505
    [No Abstract]   [Full Text] [Related]  

  • 27. Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?
    Poolpol K; Gadner B; Neururer S; Mellmann A; Karch H; Orth D; Würzner R
    Int J Immunogenet; 2011 Oct; 38(5):383-7. PubMed ID: 21649859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency.
    Bouts AH; Roofthooft MT; Salomons GS; Davin JC
    Pediatr Nephrol; 2010 Dec; 25(12):2547-8. PubMed ID: 20652818
    [No Abstract]   [Full Text] [Related]  

  • 29. Membrane cofactor protein and factor I: mutations and transplantation.
    Kavanagh D; Goodship TH
    Semin Thromb Hemost; 2006 Mar; 32(2):155-9. PubMed ID: 16575690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H.
    Sánchez-Corral P; González-Rubio C; Rodríguez de Córdoba S; López-Trascasa M
    Mol Immunol; 2004 May; 41(1):81-4. PubMed ID: 15140578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing evidence that genetic variation in complement factor H related 5 (CFHR5) causes disease: a commentary on 'Atypical haemolytic uremic syndrome and genetic aberrations in the complement factor-H-related 5 gene'.
    Maxwell PH
    J Hum Genet; 2012 Aug; 57(8):473-4. PubMed ID: 22739721
    [No Abstract]   [Full Text] [Related]  

  • 32. Complement dysfunction in hemolytic uremic syndrome.
    Zipfel PF; Skerka C
    Curr Opin Rheumatol; 2006 Sep; 18(5):548-55. PubMed ID: 16896298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Fremeaux-Bacchi V; Noris M; Goodship T; Remuzzi G; Atkinson JP
    Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P
    Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eculizumab for atypical hemolytic-uremic syndrome.
    Nürnberger J; Philipp T; Witzke O; Opazo Saez A; Vester U; Baba HA; Kribben A; Zimmerhackl LB; Janecke AR; Nagel M; Kirschfink M
    N Engl J Med; 2009 Jan; 360(5):542-4. PubMed ID: 19179328
    [No Abstract]   [Full Text] [Related]  

  • 36. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.
    Zimmerhackl LB; Hofer J; Cortina G; Mark W; Würzner R; Jungraithmayr TC; Khursigara G; Kliche KO; Radauer W
    N Engl J Med; 2010 May; 362(18):1746-8. PubMed ID: 20445192
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-C5 as prophylactic therapy in atypical hemolytic uremic syndrome in living-related kidney transplantation.
    Pelicano MB; de Córdoba SR; Diekmann F; Saiz M; Herrero S; Oppenheimer F; Campistol JM
    Transplantation; 2013 Aug; 96(4):e26-9. PubMed ID: 23958887
    [No Abstract]   [Full Text] [Related]  

  • 38. Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H.
    Riedl M; Rosales A; Zimmerhackl LB; Jungraithmayr T
    Pediatr Transplant; 2011 May; 15(3):225-8. PubMed ID: 21492349
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial and recurrent forms of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura.
    Noris M; Remuzzi G
    Contrib Nephrol; 2001; (136):125-39. PubMed ID: 11688376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.